PKM and COVID-19: PKM2 has also been shown to have higher expression in patients with severe coronavirus disease 2019 (COVID-19), suggesting that increased PKM2 is involved in the metabolic reprogramming process of patients with severe COVID-19, thus participating in the immune response induced by COVID-19 (30).